Privacy Policy

PLEASE READ THIS PRIVACY POLICY CAREFULLY BEFORE USING OUR SERVICES OR WEBSITE.

IMPORTANT NOTE - Our Notice of Privacy Practices is a separate document that governs how protected health information ("PHI") about you may be used and disclosed in connection with the health care services in accordance with the Health Insurance Portability and Accountability Act (“HIPAA”).

I. Introduction
This Privacy Policy (the “Privacy Policy”) describes how RIVO, LLC collects and uses Personal Data about you through the use of our Website, and through email, text, and other electronic communications between you and RIVO. The terms “we”, “us”, “our” and “RIVO” refer to RIVO, LLC, a Delaware corporation.

RIVO respects your privacy, and we are committed to protecting it through our compliance with this policy. This Privacy Policy describes the types of information we and our affiliates, including certain affiliated professional entities (collectively, “RIVO”, “we”, “our”, or “us”) may collect from you or that you may provide when you use RIVO through our website (“website” or the “Platform”).

This Privacy Policy also describes our practices for collecting, using, maintaining, protecting, and disclosing that information. Use of the Platform is governed by this Privacy Policy and our Terms of Service. This Privacy Policy is incorporated into our Terms of Service. All capitalized terms used in this Privacy Policy, but not defined herein, have the meanings assigned to them in the Terms of Service. By accessing or using the Platform, you acknowledge that you have read, understood and agreed to be legally bound by and comply with this Privacy Policy and our Terms of Service. If any term in this Privacy Policy is unacceptable to you, please do not use the Platform or provide any Personal Information. This Privacy Policy may change from time to time and your use of the Platform after we make changes is deemed to be acceptance of those changes, so please check this Privacy Policy periodically for updates.

This Privacy Policy does not apply to information collected by any third-party, including through any application or content (including advertising) that may link to, be embedded on, or otherwise accessible from or on the Platform. Also, you may be subject to different privacy policies or terms of service for other websites or applications.

RIVO is committed to protecting your privacy. We provide this Privacy Policy to explain the type of information we collect and to inform you of the specific practices and guidelines that protect the security and confidentiality of personal information.

II. Information We Collect About You and How It’s Collected

Information About You and Your Health Care Treatment and Payment

We collect several types of information from and about users of our Platform, including:

Information by which you may be personally identified, such as name, mailing address, email address, telephone number and account information, postal address, gender, occupation, billing and collection information that you provide to us, information related to your eligibility, or any other information collected on the Platform that is defined as personally identifiable information under applicable law (“Personal Information”).

Health-related information, such as clinical history and condition, and any other information exchanged in emails, texts, chats or calls between you and RIVO.

Information about your Internet connection, the equipment you use to access our Platform, and usage details.

Information about you, such as whether you are a current user, your product interests, location or demographics, or information related to your inquiry or request.

Any other information we specifically request.

We collect this information:

Directly from you when you provide it to us.

Automatically as you navigate through the Platform (e.g., usage details, IP address, and information collected through cookies, web beacons, and other tracking technologies).

From third parties with whom we work to provide you services, such as physicians, medical professionals, and pharmacies.

Information You Give to Us

The information we collect on or through our Platform may include:

Information that we collect when you browse our website. Even without creating an account, we still may collect from you some of the information described in this Section II.

Information that you provide on our Platform, including information provided when you sign in or register for an account on the Platform or for services provided by one of our affiliates, or through communications with you through the Platform or as a result of any healthcare services.

Information to process or respond to your inquiries related to requests for treatment, payment, customer service; and when you provide feedback on our Platform, including payment processing information that includes billing information, such as a name, address, email address, and payment card information. When you provide or update your payment processing information, we transmit the payment via an encrypted connection to a third-party credit card processor. RIVO does not collect or store your full credit card details.

Records and copies of your correspondence (including email addresses) if you contact us, such as when you report an issue with our Platform or other services.

Information that you provide for display or posting on the Platform, including information provided in social media and/or testimonials. If you provide a testimonial, your first name will be posted along with the testimonial. Please remember that testimonials are located in the public areas of our Platform. Do not provide information for display or posting on the Platform that you would not want others to save or share.

Your search queries on the Platform.

As with many other websites and applications, as you navigate through and interact with our Platform, we may use automatic data tracking technologies to collect certain information about your equipment, browsing actions, and patterns.

The Platform may utilize “cookies” to improve the functionality of the Platform. Cookies are text files that are sent by servers to web browsers and stored on your computer. They tell us which parts of the Platform you’ve visited so RIVO can alert you to software compatibility issues and save your preferences for future visits to the Platform.

For more information about how RIVO utilizes cookies, you can visit our Cookie Policy.

III. How We Use Your Information

We may use information collected about you, including Personal Information, in the following ways:

To complete any registration or other transactions or actions you request online.

For treatment, payment, or healthcare operational purposes.

To communicate with you about our healthcare services and information, products, and services that you request from us.

To administer your account.

To operate the Platform and perform services associated with the Platform.

To provide you with information you have requested.

To create de-identified information.

To measure the effectiveness of communications.

To better understand our audience.

To enhance safety and security.

To design and develop new services.

To notify you about changes to our services.

To enforce this Privacy Policy.

For any purpose where you have given consent.

To comply with applicable laws.

IV. Disclosure of Your Information

We may disclose Personal Information that we collect or you provide as described in this Privacy Policy as follows:

For treatment, payment, or healthcare operations purposes.

To service providers that assist us.

To medical providers including physicians, healthcare facilities, pharmacies, and laboratories.

To RIVO and its affiliated professional entities’ employees or service providers.

To our affiliates and their employees.

To fulfill the purpose for which you provide it.

To third-party payment processors.

To comply with applicable laws.

To entities assisting with marketing.

For any purpose disclosed when you provide the information.

To protect the rights, property, or safety of RIVO, our customers, or others.

With respect to de-identified information, for any purpose without restriction.

In the event of a sale, merger, consolidation, or restructuring.

VII. Third-Party Platforms

Our Platform may contain links or references to other websites outside of our control. This Privacy Policy does not apply to third-party websites. RIVO encourages you to read the privacy policies of those websites.

RIVO DOES NOT CONTROL AND IS NOT RESPONSIBLE FOR WHAT THIRD PARTIES DO IN CONNECTION WITH THEIR WEBSITES.

VIII. No Services To Persons Under The Age of 18

RIVO does not knowingly provide services to minors under 18.

IX. California Resident Privacy Rights

If you are a resident of California, the California Consumer Privacy Act (“CCPA”) provides you with additional rights regarding your Personal Information.

(Section content remains the same except brand name updated to RIVO.)

IV. How to Exercise Your Privacy Rights

For “Right to Know” and “Right to Deletion” requests, please submit a request by writing to the Compliance Officer at:

hello@rivohealth.co

X. Revisions to Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. The updated policy will be posted on this page.

XI. Contact Information

If you have any questions or comments about this Privacy Policy and our privacy practices, please message us through the Platform or contact us at:

RIVO, LLC
hello@rivohealth.co

RIVO guarantee

Free, expedited delivery

Doctor-led plans & coaching

No hidden fees

hello@rivohealth.co

1 (800) 705-8140

1309 Coffeen Avenue STE 1200

Sheridan Wyoming 82801

*The assessment made available on the RIVO website does not create a doctor-patient relationship between the individual completing the assessment and RIVO.

OpenLoop Health, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to

determine if an individual does not qualify for GLP-1s. The answers an individual provides to the RIVO assessment consequently determine if the individual is screened

out of eligibility for GLP-1 medication, and an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify for a prescription.

OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients.

All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and

consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3-4 weeks thereafter. Results from

compounded medications found on the RIVO platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations.

Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for

safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and

medical history.

We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of

compounded medication. RIVO does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the

website.

*The assessment made available on the RIVO website does not create a doctor-patient relationship between the individual completing the assessment and RIVO. OpenLoop Health, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the RIVO assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify for a prescription. OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients. All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3-4 weeks thereafter. Results from compounded medications found on the RIVO platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history. We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. RIVO does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Pharmacy Providers

We are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies

to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

Pharmacy Providers

We are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs and arms in the first month. Patients exercised daily and ate a

reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone.

RIVO patients typically result in 1-2 lbs per week weight loss after 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using

medication or starting any weight loss program. *Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4

mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.

*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs and arms in the first month. Patients exercised daily and ate a reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. RIVO patients typically result in 1-2 lbs per week weight loss after 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using medication or starting any weight loss program. *Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.

Medication is included in the cost of the RIVO Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be

prescribed for weight loss. The trademarks, service marks, trade names (Wegovy® ,Ozempic®), and products displayed on this Internet site are protected and belong to

their respetive owners. Medical treatment is provided by “CareGLP Affiliated P.C.s,” and OpenLoop Health, affiliated networks for medical professional corporations and

associations. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative

of RIVO patient experience.

Medication is included in the cost of the RIVO Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy® ,Ozempic®), and products displayed on this Internet site are protected and belong to their respetive owners. Medical treatment is provided by “CareGLP Affiliated P.C.s,” and OpenLoop Health, affiliated networks for medical professional corporations and associations. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative of RIVO patient experience.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or

warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or AI portraying doctors and

are not licensed medical professionals.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or AI portraying doctors and are not licensed medical professionals.

Testimonials on the website are from RIVO patients. For patient privacy, images representing those testimonials may use models or AI.

Terms & Conditions

Privacy Practices

Refund Policy

Medical Consent

For California Residents